MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    Efficacy of opicapone according to different levodopa daily intakes in Parkinson’s disease patients with motor fluctuations

    G. Ebersbach, W. Poewe, J. Ferreira, D. Magalhaes, J. Rocha, P. Soares-da-Silva (Beelitz-Heilstätten, Germany)

    Objective: To evaluate the efficacy of opicapone (OPC) in Parkinson’s disease (PD) patients with motor fluctuation according to different levodopa daily intakes. Background: OPC proved…
  • MDS Virtual Congress 2021

    Randomized, Placebo-Controlled Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of ABBV-0805, an Anti-Alpha-Synuclein Monoclonal Antibody in Healthy Subjects

    H. Kalluri, C. Zadikoff, L. Rueter, O. Graff, H. Xiong (North Chicago, USA)

    Objective: To evaluate the safety, tolerability, pharmacokinetics (PK), and immunogenicity of ABBV-0805 following administration of single ascending doses of ABBV-0805, administered as intravenous (IV) infusions…
  • MDS Virtual Congress 2021

    Decreased expression of trace amines receptors on lymphocytes in Parkinson’s disease

    Z. Muruzheva, I. Ivleva, V. Maystrenko, O. Tumashova, M. Karpenko (Saint-Petersburg, Russian Federation)

    Objective: To determine the expression of TAAR1 and TAAR2 mRNA in leukocytes of patients with Parkinson's disease, depending on the stage of the disease and…
  • MDS Virtual Congress 2021

    Potential drug-drug interactions in hospitalized patients with Parkinson’s disease from tertiary center in Serbia

    D. Aleksic, S. Stefanovic, M. Milosavljevic, J. Milosavljevic, S. Jankovic (Kragujevac, Serbia)

    Objective: The aim of this study was to identify predictors of potential drug-drug interactions in patients suffering from Parkinson’s disease.The aim of this study was…
  • MDS Virtual Congress 2021

    Assessment of Fluctuating Parkinson’s Disease with Sensor-Based Home Monitoring-Feasibility Results

    T. Fay-Karmon, N. Galor, B. Heimler, R. Bartsch, A. Zilka, V. Livneh, M. Plotnik, S. Hassin-Baer (Ramat Gan, Israel)

    Objective: To implement home-based monitoring (HBM) using wearable devices, a smartphone dedicated app and patient reported outcomes in order to provide a more comprehensive picture…
  • MDS Virtual Congress 2021

    Findings from a Community-based LOUD Crowd® Program for People with Parkinson Disease

    S. Parveen, A. Mandaville (Stillwater, USA)

    Objective: SPEAK OUT!® and LOUD Crowd® programs target the communicative functioning of people with Parkinson disease (PD). The current study includes findings from a year-long…
  • MDS Virtual Congress 2021

    Combined Plantar Stimulations Using a Novel Parkinson Shoe benefit Parkinson’s Disease Patients with Unresponsive Freezing of Gait

    W. Phuenpathom, P. Panyakaew, S. Fungtammasan, P. Vateekul, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To explore the effect of combined vibratory and pressure stimulations in PD patients with unresponsive FOG and develop the innovative PD shoe. Background: Freezing…
  • MDS Virtual Congress 2021

    Levodopa responsive gait dynamics in ON- and OFF-state freezing of gait in Parkinson’s disease

    T. Virmani, L. Pillai, A. Glover, R. Landes (Little Rock, USA)

    Objective: To determine which spatiotemporal gait parameters respond to levodopa in Parkinson’s patients with levodopa ON- and OFF-state gait freezing. Background: Levodopa-ON-state gait freezing is…
  • MDS Virtual Congress 2021

    EPIDEMIOLOGICAL OVERVIEW OF PARKINSON’S DISEASE IN BRAZIL

    S. Moura, R. Oliveira, L. Cruz, N. Cruz, A. Moura, N. Oliveira (Salvador, Brazil)

    Objective: To describe the epidemiological profile in patients hospitalized with Parkinson's Disease in Brazil during the years 2015 to 2020. Background: Parkinson's disease (PD) is…
  • MDS Virtual Congress 2021

    Machine Learning (ML) Prediction of Parkinson’s Disease (PD) Risk and Nigral Neuron Density

    I. Karabayir, L. Butler, S. Goldman, R. Kamaleswaran, F. Gunturkun, R. Davis, GW. Ross, H. Petrovitch, K. Masaki, C. Tanner, G. Tsivgoulis, A. Alexandrov, O. Akbilgic (Maywood, USA)

    Objective: To investigate associations between nigral neuron density and ML-based PD risk prediction. Background: Early identification of persons at high risk for developing PD is…
  • « Previous Page
  • 1
  • …
  • 498
  • 499
  • 500
  • 501
  • 502
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley